Skip to main content
David Fisher, MD, Plastic Surgery, Charlotte, NC

DavidCFisherMDFACS

Plastic Surgery Charlotte, NC

Head & Neck, Pediatric Craniofacial Plastic Surgery, Pediatric Plastic Surgery, Plastic & Reconstructive Microsurgery

Physician

Dr. Fisher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fisher's full profile

Already have an account?

  • Office

    1025 Morehead Medical Dr
    Ste 200
    Charlotte, NC 28204
    Phone+1 704-446-6810

Summary

  • Dr. David Fisher is a plastic surgeon in Charlotte, NC and is affiliated with multiple hospitals in the area, including Carolinas Medical Center, Atrium Health University City, and Carolinas Medical Center.

Education & Training

  • The Royal Children’s Hospital, Melbourne
    The Royal Children’s Hospital, Melbourne Fellowship, 2014 - 2015
  • Auckland City Hospital
    Auckland City HospitalFellowship, 2010 - 2011
  • Wake Forest University Baptist Medical Center
    Wake Forest University Baptist Medical CenterResidency, Plastic Surgery - Integrated, 2004 - 2010
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2004

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2004 - 2025
  • American Board of Plastic Surgery Plastic Surgery

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL / SLLA Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or R...
    David C. Fisher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL / SLLA Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or R...
    David C. Fisher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Congenital FVIII/IX or VWF Deficiency Does Confer a Lower Rate of Myocardial Infarction-Related Mortality Despite Decreased Cardiovascular Interventions 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019